Diploma (LON:DPLM) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Diploma PLC (LON:DPLM)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 4,252.69 ($56.60) and traded as high as GBX 4,260 ($56.69). Diploma shares last traded at GBX 4,251.86 ($56.59), with a volume of 364,165 shares.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. increased their price objective on Diploma from GBX 4,370 ($58.16) to GBX 4,420 ($58.82) and gave the stock a “neutral” rating in a research note on Tuesday, January 14th.

Diploma Trading Down 0.6%

The stock has a market capitalization of £5.65 billion, a PE ratio of 48.69, a P/E/G ratio of 2.82 and a beta of 0.75. The firm has a 50 day moving average price of GBX 3,926.44 and a 200 day moving average price of GBX 4,252.69. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17.

Insider Transactions at Diploma

In related news, insider Ian El-Mokadem acquired 500 shares of the stock in a transaction dated Monday, March 24th. The stock was purchased at an average cost of GBX 3,948 ($52.54) per share, with a total value of £19,740 ($26,270.96). Also, insider David S. Lowden purchased 750 shares of the firm’s stock in a transaction that occurred on Friday, March 21st. The shares were acquired at an average cost of GBX 3,928 ($52.28) per share, with a total value of £29,460 ($39,206.81). Company insiders own 0.52% of the company’s stock.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.